Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Anthony, auction, authoritative, Ben, beneficially, biopharmaceutical, Bulletin, buy, cancellation, chair, Colin, Committee, consideration, coverage, desire, digestive, dismissed, disorder, Dor, earlier, fee, female, force, framework, hypoactive, IBS, immaterial, intangible, LLC, located, Marcel, medical, Milfam, Mony, Neill, opposition, partially, percent, practicable, practice, quantifying, rediscovery, reimburse, reimbursed, reimbursement, reorganization, reset, resigned, restructure, routinely, SAB, significantly, single, slate, sought, Steering, stipulation, tangible, tianeptine, Treasurer, Trust, unchanged, unduly, Waiver
Removed:
commence, finance, growth, half, Item, pursue
Filing tables
Filing exhibits
Related press release
Pharmos similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Pharmos Corporation (the “Company”) on Form 10-Q for the period ended September 30, 2006 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Haim Aviv, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C § 1350, as adopted pursuant to § 906 of the Sarbanes -Oxley Act of 2002, that:
1) | The Report fully complies with the requirements of section 13 (a) or 15(d) of the Securities Exchange Act of 1934; and |
2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Haim Aviv | ||
Haim Aviv, Chief Executive Officer | ||
November 10, 2006 |